Publication date: 
1 March 2014
Last updated: 
31 July 2018
Publication type: 
Intended audience: 
Health professionals

This document contains Australian Technical Advisory Group on Immunisation (ATAGI) advice for immunisation providers about the use of Bexsero®, a recombinant multicomponent meningococcal B vaccine (4CMenB).

It includes information about transport, storage and handling, dosage and administration, recommendations, contraindications, adverse events and references to more detailed information.

These files may not be suitable for users of assistive technology. Request an accessible format.